SEC Tracker
Get the app

Verona Pharma

OrbiMed Private Investments VI (Shareholder) plans to sell 2,575,811 shares, about $60.4M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: May 11, 2023
  2. Broker: Themis Trading LLC
  3. Shares acquired by: Private placement

All of OrbiMed Private Investments VI's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 80,000 shares at $22.26 on May 11, 2023 · Form 4
  • Sold 43,200 shares at $21.64 on May 12, 2023 · Form 4
  • Sold 14,400 shares at $21.96 on May 15, 2023 · Form 4
  • Sold 345,313 shares at $20 on May 15, 2023 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Verona Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. America Great Health AAGH
  2. AbbVie ABBV public float $325.1B, Jun 30, 2025
  3. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  4. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  5. Arbutus Biopharma ABUS public float $472M, Jun 30, 2025